Working… Menu

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03062423
Recruitment Status : Completed
First Posted : February 23, 2017
Last Update Posted : August 1, 2019
Al-debeiky pharma
Information provided by (Responsible Party):
Genuine Research Center, Egypt